A permanent operating base for biotechnology in Muscat.

Maak is seeking an approximately 1,000 m² plot at Innovation Park Muscat for an integrated headquarters and phased biotechnology facility.

Proposed location · formal site allocation and agreement required
Illustrative facility concept

Design direction for the planned Oman headquarters and biotechnology facility

Immediate operating capacity with room for long-term expansion.

The initial building will integrate an approximately 100 m² headquarters office with meeting space, R&D and quality-support areas, secure records and controlled zones for material receipt, quarantine, sampling, storage and dispatch.

Programme direction, quality oversight, data, intellectual property and regional coordination will be based in Oman. Specialised peptide synthesis and advanced analytical testing will continue through qualified international partners, allowing the Muscat operation to scale without duplicating capital-intensive specialist infrastructure.

What the first facility
is designed to do.

The building brings the functions Maak controls into one secure and expandable Oman operation.

LEAD

Headquarters & governance

Company management, programme direction, partner reviews, finance, commercial coordination and institutional meetings.

REVIEW

R&D & quality support

Permitted sample handling, technical review, method support, quality documentation and controlled research records.

CONTROL

Material operations

Documented receipt, quarantine, sampling or inspection, controlled storage, inventory status and dispatch.

CONNECT

Specialist network

International synthesis, advanced testing, logistics and project-specific scientific expertise coordinated from Muscat.

One site designed
to grow with the company.

The plot consolidates today's operating requirements while preserving space for future laboratory and technical capability through 2040.

01

Integrated headquarters

Approximately 100 m² of office space for management, programme coordination and partner meetings.

02

Controlled operations

Dedicated areas for quality support, secure records and traceable material receipt, storage and dispatch.

03

Technical expansion

Additional laboratory and technical areas introduced as programmes, staffing and authorised activities grow.

04

Regional capability

A Muscat base for international research partnerships and future licensed supply across selected markets.

International biotechnology activity managed from Muscat.

The facility anchors company ownership, skilled work, research relationships and regional operations in Oman while connecting IPM to a qualified international execution network.

01Private investment
02Specialised employment
03Research partnerships
04IP & data in Oman
05Regional operations

Discuss the IPM facility and Oman biotechnology programme.

Contact Maak

Discuss a peptide programme, scientific collaboration or strategic partnership.

Contact Maak